Evidence map›Paper›PMID 35264593›Full record

ArticleScientific reports2022

Quantitative proteomic analysis of the lysine acetylome reveals diverse SIRT2 substrates.

Hui Zhang, Eric B Dammer, Duc M Duong, Diana Danelia, Nicholas T Seyfried, David S Yu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hui Zhang *Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd NE, C3008, Atlanta, GA, 30322, USA.
Eric B Dammer *Department of Biochemistry and Winship Cancer Institute, Emory University School of Medicine, 4133 Rollins Research Building, Atlanta, GA, 30322, USA.
Duc M DuongDepartment of Biochemistry and Winship Cancer Institute, Emory University School of Medicine, 4133 Rollins Research Building, Atlanta, GA, 30322, USA.
Diana DaneliaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd NE, C3008, Atlanta, GA, 30322, USA.
Nicholas T Seyfried *Department of Biochemistry and Winship Cancer Institute, Emory University School of Medicine, 4133 Rollins Research Building, Atlanta, GA, 30322, USA. nseyfri@emory.edu.
David S Yu *Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd NE, C3008, Atlanta, GA, 30322, USA. dsyu@emory.edu.
Emory University · US

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Mechanisms of SIRT2 Function in the Replication Stress ResponseR01CA178999 · NCI · EMORY UNIVERSITY · PI YU, DAVID SUNG-WEN · 2013 to 2023
$3.5M
Elucidating SAMHD1 in DNA Double-Strand Break Repair (Supplement)R01CA254403 · NCI · EMORY UNIVERSITY · PI KIM, BAEK, YU, DAVID SUNG-WEN · 2020 to 2024
$2.9M
Elucidating control of BRCA1 by SIRT2 in DNA double-strand break repairF31CA225124 · NCI · EMORY UNIVERSITY · PI MINTEN, ELIZABETH · 2018 to 2020
$94k
NCI NIH HHS F31 CA225124NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA178999NCI NIH HHS R01 CA254403
6 · The paper itself

Abstract

Sirtuin 2 (SIRT2) is a NAD+-dependent deacetylase, which regulates multiple biological processes, including genome maintenance, aging, tumor suppression, and metabolism. While a number of substrates involved in these processes have been identified, the global landscape of the SIRT2 acetylome remains unclear. Using a label-free quantitative proteomic approach following enrichment for acetylated peptides from SIRT2-depleted and SIRT2-overexpressing HCT116 human colorectal cancer cells, we identified a total of 2,846 unique acetylation sites from 1414 proteins. 896 sites from 610 proteins showed a > 1.5-fold increase in acetylation with SIRT2 knockdown, and 509 sites from 361 proteins showed a > 1.5-fold decrease in acetylation with SIRT2 overexpression, with 184 proteins meeting both criteria. Sequence motif analyses identified several site-specific consensus sequence motifs preferentially recognized by SIRT2, most commonly KxxxxK(ac). Gene Ontology, KEGG, and MetaCore pathway analyses identified SIRT2 substrates involved in diverse pathways, including carbon metabolism, glycolysis, spliceosome, RNA transport, RNA binding, transcription, DNA damage response, the cell cycle, and colorectal cancer. Collectively, our findings expand on the number of known acetylation sites, substrates, and cellular pathways targeted by SIRT2, providing support for SIRT2 in regulating networks of proteins in diverse pathways and opening new avenues of investigation into SIRT2 function.

Indexed as

Colorectal NeoplasmsProteomicsSirtuin 2AcetylationHumansLysineProteinsLysineProteinsSIRT2 protein, humanSirtuin 2

Identifiers

PMID35264593
PMCPMC8907344
OpenAlexW4220953040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.